Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing Escherichia coli Isolates from Tunisia.

Jaidane N, Naas T, Fayad S, Châtre P, Mansour W, Bouaziz A, François P, Fraysseix LD, Iorga BI, Al Laham NA, Tilouche L, Barguellil F, Haenni M

Open source

DOI
10.3390/antibiotics15080802
Published
2026 Aug 18
Container
Antibiotics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics15080802,
  title = {Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing Escherichia coli Isolates from Tunisia.},
  author = {Jaidane N and Naas T and Fayad S and Châtre P and Mansour W and Bouaziz A and François P and Fraysseix LD and Iorga BI and Al Laham NA and Tilouche L and Barguellil F and Haenni M},
  year = {2026},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics15080802},
  url = {https://doi.org/10.3390/antibiotics15080802}
}

RIS

TY  - JOUR
TI  - Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing Escherichia coli Isolates from Tunisia.
AU  - Jaidane N
AU  - Naas T
AU  - Fayad S
AU  - Châtre P
AU  - Mansour W
AU  - Bouaziz A
AU  - François P
AU  - Fraysseix LD
AU  - Iorga BI
AU  - Al Laham NA
AU  - Tilouche L
AU  - Barguellil F
AU  - Haenni M
PY  - 2026
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics15080802
UR  - https://doi.org/10.3390/antibiotics15080802
ER  -

APA

N, J., T, N., S, F., P, C., W, M., A, B., P, F., LD, F., BI, I., NA, A. L., L, T., F, B., & M, H. (2026). Reduced Susceptibility to Cefiderocol Among Clinical MCR-1-Producing Escherichia coli Isolates from Tunisia.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics15080802

Source records